Photothermal/NO combination therapy from plasmonic hybrid nanotherapeutics against breast cancer

Keyphrases

• Breast Cancer 100%
• Photothermal 100%
• Nanotherapeutics 100%
• NO Production 100%
• Combination Therapy 100%
• Plasmon Hybridization 100%
• NIR-II 100%
• Tumor 66%
• Semiconductors 66%
• Photoacoustic Imaging 66%
• Hybrid Nanodevice 66%
• Nanotheranostics 66%
• Au Nanostars 66%
• Thermal NO 66%
• Fluorescence Imaging 33%
• Oxidative Stress 33%
• Laser Irradiation 33%
• Plasmonics 33%
• Nanodevices 33%
• Therapeutic Efficacy 33%
• Plasmon 33%
• Energy Transfer 33%
• Cancer Treatment 33%
• Pyrene 33%
• Localized Surface Plasmon Resonance 33%
• Tumor Growth 33%
• Thermal Response 33%
• Promising Strategies 33%
• Tyrosine Residue 33%
• Cell Apoptosis 33%
• Mitochondrial Proteins 33%
• Graphene Quantum Dots 33%
• Dual-modality 33%
• Inhibit Tumor 33%
• Hybrid Nanoparticles 33%
• Nitration 33%
• Tumor Inhibition 33%
• Photothermal Treatment 33%
• Triple-negative Breast Cancer 33%
• Hyperthermia Applications 33%
• Thermal Ablation 33%
• Enhanced Retention 33%
• Imaging-guided 33%
• Photo-triggered 33%
• Retention Effect 33%
• Nitrosative Stress 33%
• 4T1 Breast Cancer 33%
• Enhanced Permeation 33%
• Permeation Effect 33%
• Photothermal Response 33%
• NO Therapy 33%
• NIR-II Laser 33%
• Gas Therapy 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Breast Cancer 100%
• Combination Therapy 100%
• Neoplasm 50%
• Malignant Neoplasm 25%
• Nanoparticle 25%
• Tumor Growth 25%
• Pyrene Derivative 25%
• Polyethylene Glycol 25%
• Cancer Inhibition 25%
• Hyperthermia 25%
• Triple Negative Breast Cancer 25%
• Graphene Quantum Dot 25%
• Mitochondrial Protein 25%

Material Science

• Tumor 100%
• Nanodevice 75%
• Surface (Surface Science) 50%
• Nanoparticle 25%
• Polyethylene Glycol 25%
• Graphene Quantum Dot 25%
• Nitration 25%
• Gas Therapy 25%
• Tyrosine 25%